Description and Brand Names
Drug information provided by: Micromedex
US Brand Name
Ibrutinib is used to treat mantle cell lymphoma (MCL) in patients who have received at least one previous treatment with another medicine.
Ibrutinib interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by ibrutinib, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Some unwanted effects, such as a skin rash, may not be serious but may cause concern. Some of the unwanted effects do not occur until months or years after the medicine is used.
Before you begin treatment with ibrutinib, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: